[DOI] [PMC free article] [PubMed] [Google Scholar] 8.Alhadeff A.L., Rupprecht L.E., Hayes M.R
There was also a twofold increase in vasodilatory capacity in patients treated with saxagliptin versus placebo, signifying an improvement in the eye vasculature, although the increase was nonsignificant
[4] [5] In the brain, GLP-1 receptor activation in appetite-regulating centers reduces hunger and increases satiety, leading to decreased caloric intake and weight loss
These medications can provide meaningful benefits for weight management and metabolic health, but questions about long-term use, maintenance, and stopping treatment are common
This stimulation is associated with improved circulation and mitochondrial efficiency, supporting cellular energy utilization
The frontrunner is the Zio patch , a small adhesive device placed on your chest that records your hearts electrical activity continuously for up to 14 days